0HV Stock Chart & Stats
€23.20
-€0.40(-1.79%)
At close: 4:00 PM EDT
€23.20
-€0.40(-1.79%)
Day’s Range― - ―
52-Week Range€16.20 - €25.80
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€3.38B
Enterprise Value€5.00K
Total Cash (Recent Filing)€1.13B
Total Debt (Recent Filing)€1.59B
Price to Earnings (P/E)40.2
Beta0.71
Next Earnings
Nov 04, 2026EPS Estimate
0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.59
Shares Outstanding160,617,700
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.74
Price to Book (P/B)1.17
Price to Sales (P/S)1.34
P/FCF Ratio15.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€26.68Price Target Upside14.98% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
EPS Forecast (FY)1.35
Revenue Forecast (FY)€2.53B
Bulls Say, Bears Say
Bulls Say
Broad-based Revenue Growth And Share GainsBroad-based growth across the first half indicates improving demand and commercial execution rather than reliance on a single product or quarter. Continued expansion in consumables, diagnostics, and digital offerings can strengthen Envista’s market position and support durable revenue momentum.
Sustainable Margin ExpansionHigher gross and EBITDA margins show that recent growth is translating into stronger operating leverage and product economics. If maintained, this improvement can create greater earnings resilience, support continued investment in innovation, and provide more flexibility against cost pressures.
Strong Cash Generation And ConversionConsistently strong free-cash-flow conversion gives Envista internally generated funding for research, commercial initiatives, acquisitions, and shareholder returns. Improving cash generation also strengthens the company’s ability to manage operating volatility without relying heavily on external financing.
Bears Say
China VBP Pricing PressurePotentially substantial China reimbursement-driven price cuts could reduce revenue quality and margins in implants and orthodontics. Although management expects some volume and share recovery, the timing and net impact remain uncertain, creating a material multi-quarter pressure on growth.
Uneven Profitability And Thin Net MarginsThe return to profitability is encouraging, but a thin net margin leaves limited protection if demand weakens or costs rise. Historical earnings volatility also makes sustainable profit expansion less proven and could constrain capital allocation if operating conditions deteriorate.
Cyclical Exposure In Implants And OrthodonticsExposure to elective procedures and practice investment cycles can make demand less consistent than recurring consumables alone would suggest. Regional differences may further complicate execution, causing uneven growth and making results more sensitive to local economic conditions.
0HV FAQ
What was Envista Holdings Corp’s price range in the past 12 months?
Envista Holdings Corp lowest stock price was €16.20 and its highest was €25.80 in the past 12 months.
What is Envista Holdings Corp’s market cap?
Envista Holdings Corp’s market cap is €3.38B.
When is Envista Holdings Corp’s upcoming earnings report date?
Envista Holdings Corp’s upcoming earnings report date is Nov 04, 2026 which is in 36 days.
How were Envista Holdings Corp’s earnings last quarter?
Envista Holdings Corp released its earnings results on Aug 05, 2026. The company reported €0.361 earnings per share for the quarter, beating the consensus estimate of €0.295 by €0.066.
Is Envista Holdings Corp overvalued?
According to Wall Street analysts Envista Holdings Corp’s price is currently Undervalued.
Does Envista Holdings Corp pay dividends?
Envista Holdings Corp does not currently pay dividends.
What is Envista Holdings Corp’s EPS estimate?
Envista Holdings Corp’s EPS estimate is 0.31.
How many shares outstanding does Envista Holdings Corp have?
Envista Holdings Corp has 160,617,700 shares outstanding.
What happened to Envista Holdings Corp’s price movement after its last earnings report?
Envista Holdings Corp reported an EPS of €0.361 in its last earnings report, beating expectations of €0.295. Following the earnings report the stock price went up 4.386%.
Which hedge fund is a major shareholder of Envista Holdings Corp?
Currently, no hedge funds are holding shares in DE:0HV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Envista Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€26.68 (14.98% Upside)
€26.68 (14.98% Upside)
Blogger Sentiment
Bullish
DE:0HV Sentiment 90%
Sector Average 64%
Sector Average 64%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
19.80%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-1.19%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Envista Holdings Corp
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
0HV Company Deck
0HV Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call reported a strong quarter with broad-based revenue growth, meaningful margin expansion, large EPS and free-cash-flow improvement, a strengthened balance sheet and raised full-year guidance. Operational highlights included robust E&C performance, double-digit Spark growth, successful new product launches, and continued share gains. Headwinds and risks were manageable and largely named and quantified: China VBP-driven price pressure and timing uncertainty, a Q4 billing-day calendar headwind, tariff-related costs, and the end of a small deferral tailwind. Overall, management framed the issues as addressable while emphasizing continued momentum, investment in R&D and commercial initiatives, and confidence in the raised guidance.View all DE:0HV earnings summaries0HV Revenue Breakdown
63.99% Specialty Products & Technologies
36.01% Equipment & Consumables

0HV Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€26.68
▲(14.98% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month










